Biotech/Biomedical
News Category

Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial
Quantum BioPharma's agreement with Thermo Fisher's clinical research business advances its novel neuroprotective multiple sclerosis drug Lucid-MS into...

VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing in Cancer Research
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could accelerate clinical advancement, cut costs and timelines, and significantly ...

SS Innovations Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
SS Innovations International Inc. is emerging as a key player in telerobotic surgery, with 195 telesurgeries performed using its SSi Mantra system and...

Lantern Pharma's Taiwan Approvals for HARMONIC Trial Could Accelerate Precision Oncology Development
Lantern Pharma's regulatory approvals in Taiwan for its Phase 2 HARMONIC trial of LP-300 mark a significant step forward in addressing an unmet need f...

Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial, Testing Novel Neuroprotective Approach
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a mult...

VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing in Cancer Therapy Development
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to cut animal testing and accelerate preclinical development of its cancer thera...

Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial, Targeting Myelin Repair in Progressive MS
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a firs...

XORTX Therapeutics Targets FDA New Drug Application for XORLO as Gout Prevalence Projected to Surge
XORTX Therapeutics is advancing XORLO, a proprietary oxypurinol formulation for gout, with plans to submit a New Drug Application to the FDA within a ...

C60 Power Marks National C60 Day, Highlighting Fullerene Research and Consumer Wellness
C60 Power's National C60 Day on October 9 honors the 1996 Nobel Prize in Chemistry for fullerenes, drawing attention to ongoing antioxidant and health...

National C60 Day Highlights the Growing Importance of Carbon 60 Research and Consumer Education
C60 Power's National C60 Day on October 9 promotes awareness of carbon 60's scientific history and potential health applications, emphasizing purity a...

Gold's Recovery Signal: Bargain Buying and Falling Yields Could Mark Turning Point for Miners
Gold's second straight session of gains, driven by bargain buying, a weaker dollar, and falling Treasury yields, suggests a potential shift in market ...

Skull's Hidden Lymph Nodes May Revolutionize Brain Immunity and Cancer Treatment
New research reveals lymph node-like structures in the skull's bone marrow, suggesting a local immune defense for the brain that could lead to innovat...

Heart-Brain Protection Pioneer Jennifer S. Lawton to Receive 2026 AHA Basic Research Prize
Dr. Jennifer S. Lawton will receive the American Heart Association's 2026 Basic Research Prize for her translational research that has advanced myocar...

In Vitro ADME Studies Streamline Drug Development and Reduce Failure Risk
In vitro ADME studies are critical for early assessment of drug candidates, improving success rates and reducing costs in pharmaceutical development.

Single-Dose MVA-X Vaccine Shows Durable Protection Against Lethal Clade I Mpox in Preclinical Study
GeoVax's next-generation MVA-X vaccine provides durable single-dose protection against lethal Clade I mpox and other orthopoxviruses, potentially simp...

Financial Services Companies to Present Live at September 24 Virtual Investor Conference
B2i Digital's Financial Services Virtual Investor Conference on September 24 will feature live presentations from community banks, a logistics REIT, a...

Marygold Companies Narrows Annual Loss as USCF Investments Thrives, but UK Impairments Weigh on Fourth Quarter
The Marygold Companies reported fiscal 2026 revenue growth of 8% to $25.3 million and a narrowed net loss, but a $2.7 million write-off in its UK fina...

Onco-Innovations Aligns Manufacturing, Preclinical Work, and Clinical Planning for Lead Cancer Candidate ONC010
Onco-Innovations is integrating manufacturing, preclinical, and regulatory efforts to advance its PNKP-targeting cancer therapy ONC010 toward first-in...

VERAXA Biotech Appoints Capital Markets Veteran Raju Willener as CFO to Steer Oncology Pipeline
VERAXA Biotech has named Raju Willener as chief financial officer, bringing over 30 years of international capital markets experience as the company a...

Nano-X Imaging Builds End-to-End Platform to Transform Medical Imaging and Preventive Care
Nano-X Imaging is integrating proprietary X-ray hardware, FDA-cleared AI, cloud software, and teleradiology into a comprehensive platform, reporting s...

Apimeds Engages IBN to Boost Visibility for Blockchain and Biopharma Ventures
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has retained IBN for corporate communications, aiming to raise awareness of its diverse portfol...

Regentis Biomaterials CEO Highlights GelrinC's Potential in U.S. and European Markets
Regentis Biomaterials is advancing its GelrinC cartilage repair treatment with a U.S. pivotal trial and European commercialization efforts, targeting ...

Silo Pharma Secures U.S. Patent Allowance for PTSD Therapeutic SPC-15
Silo Pharma's U.S. patent allowance for SPC-15 strengthens its intellectual property portfolio and supports the development of a novel intranasal trea...

Bacterial Strains Influence Meningitis, Pneumonia Risks from Air Pollution, New Study Finds
A new study reveals that the risk of sepsis, meningitis, or pneumonia from air pollution depends on individual bacterial strains, highlighting the nee...

Goldman Sachs Forecasts Another Fed Rate Hike in October After September Increase
Goldman Sachs now expects another Federal Reserve rate hike in October following the Fed's unanimous 25-basis-point increase in September, a move that...

Nightfood Holdings' TechForce Robotics Expands into Pharmaceutical, Semiconductor, and Industrial Automation Markets
Nightfood Holdings is expanding its TechForce Robotics platform beyond hospitality into high-growth automation markets, including pharmaceutical and s...

Hong Kong-Led GoGlobal Task Force Visits Canada to Boost Mainland Enterprises' Global Expansion
Invest Hong Kong leads a delegation of Mainland Chinese companies to Canada to foster cross-border investment and partnerships in sustainability and l...

Peptide Wholesale Supply Expands HPLC Verification to Bulk Semaglutide and Tirzepatide Orders
Peptide Wholesale Supply now applies HPLC testing and batch traceability to bulk orders of BPC-157, Semaglutide, and Tirzepatide, enhancing analytical...

Early Clinical Trial Conversations Crucial for Small Cell Lung Cancer Patients
Patients with small cell lung cancer should ask about clinical trials at their first appointment, as emerging treatments offer new hope and improved q...

Regentis Biomaterials Advances GelrinC as Potential New Approach to Knee Cartilage Repair
Regentis Biomaterials is developing GelrinC, an off-the-shelf hydrogel implant that supports cartilage regeneration, with European approval and an FDA...

ORGANA International Courts Retail Buyers at ECRM to Expand U.S. Distribution
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to secure broader retail distribu...

Med-X Advances Nature-Cide Pest-Control Platform Ahead of Planned Nasdaq Debut
Med-X is expanding its Nature-Cide natural pest-control brand as it prepares for a Nasdaq listing, with recent OMRI certification opening opportunitie...

Telomir Pharmaceuticals' Telomir-Zn Shows Growth Inhibition in Human and Canine Osteosarcoma Models
Telomir Pharmaceuticals announced that its lead drug candidate Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines at similar low ...

Quantum BioPharma's FDA Clearance for Lucid-MS IND Marks Rare Milestone for Micro-Cap Biotech
Quantum BioPharma has received FDA clearance for its Investigational New Drug application for Lucid-MS, enabling a Phase 2 trial in multiple sclerosis...

GeoVax and CEPI Partner to Advance GEO-MVA Mpox Vaccine Phase 3 Trial with Independent Lab Network
GeoVax's agreement with CEPI to use its Centralised Laboratory Network for the GEO-MVA Phase 3 trial could accelerate development of a new mpox vaccin...

Aortic Stiffness, Not Menopause, Drives Midlife Pulse Pressure Rise in Women
New research from the Framingham Heart Study reveals that the midlife increase in pulse pressure and aortic stiffness in women begins decades before m...

Dental Design Studios Expands to Nine Phoenix Offices, Offering Full Arch Implants and Same-Day Emergency Care
Dental Design Studios' expansion to nine Phoenix-area locations under Dr. Mannie Badyal increases access to full arch implants, cosmetic dentistry, an...

Engineered Suppressor tRNAs Show Promise for Duchenne Muscular Dystrophy
Preclinical research published in Science Advances demonstrates that engineered suppressor tRNA gene therapy can restore full-length dystrophin and im...

Wellness Index Report: Translational Longevity Key To Delivering Breakthroughs To Patients
The August Wellness Index Report argues that translating longevity science into clinical care is the critical step for real progress, and announces th...

Creative Biolabs Expands Functionalized Lipid-Based Delivery Systems to Address Key Research Barriers
Creative Biolabs has broadened its lipid-based delivery development capabilities to help researchers overcome stability, targeting, and controlled rel...

Dr. Thanapoom Boonipat Scholarship for Future Doctors Opens Nationwide to Aspiring Physicians
The Dr. Thanapoom Boonipat Scholarship for Future Doctors offers a $1,000 one-time award to undergraduate students nationwide, emphasizing the importa...

LiverRight and Aegle Medical Solutions Partner to Expand Liver Disease Detection and Care
LiverRight and Aegle Medical Solutions have formed a strategic partnership to improve access to non-invasive liver assessment, specialist interpretati...

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services to Advance Biomedical Research
Creative Biolabs has expanded its single-cell multi-omics and RNA sequencing solutions, offering integrated services that enable high-resolution cellu...

Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
A comprehensive review reveals that the tumor microenvironment actively reshapes natural killer cells into distinct functional subsets, offering new t...

Nanox Expands into Costa Rica with Nanox.ARC Distribution Agreement
Nanox signs a distribution agreement with SOLME RC to bring its Nanox.ARC 3D imaging system to Costa Rica, marking its third Latin American market thi...

Life Sciences Virtual Investor Forum to Showcase Seven Companies Advancing Cancer, Fibrosis, Antibiotics, and Respiratory Imaging
The September 17 Life Sciences Virtual Investor Forum will connect investors with seven companies developing therapies for cancer, fibrosis, antibioti...


